Group 1: Lockheed Martin Corporation - Lockheed Martin's recent performance shows a strong demand for defense products, with a notable increase in contract awards [1] - The company reported a revenue growth of 7% year-over-year, reaching $67 billion, driven by increased military spending [1] - Lockheed Martin's net income rose to $6.5 billion, reflecting a 10% increase compared to the previous year [1] Group 2: Pfizer Inc - Pfizer has experienced a significant decline in revenue, with a 50% drop year-over-year, primarily due to reduced demand for COVID-19 vaccines [1] - The company's total revenue for the last quarter was reported at $12 billion, down from $24 billion in the same period last year [1] - Pfizer is focusing on diversifying its product portfolio to mitigate the impact of declining vaccine sales [1] Group 3: Schlumberger NV - Schlumberger reported a revenue increase of 20% year-over-year, reaching $8 billion, driven by higher oil prices and increased drilling activity [1] - The company's net income surged to $1.2 billion, a 25% increase compared to the previous year [1] - Schlumberger is investing in technology and digital solutions to enhance operational efficiency and capitalize on market opportunities [1]